| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Multicentre study of the determination of peak oxygen uptake and ventilatory threshold during bicycle exercise in chronic heart failure. Comparison of graphical methods, interobserver variability and influence of the exercise protocol. The VO2 French Study Group.
|
Eur Heart J
|
1991
|
0.88
|
|
2
|
Preconditioning reduces infarct size but accelerates time to ventricular fibrillation in ischemic pig heart.
|
Am J Physiol
|
1995
|
0.87
|
|
3
|
Can anaerobic threshold be used as an end-point for therapeutic trials in heart failure? Lessons from a multicentre randomized placebo-controlled trial. The VO2 French Study Group.
|
Eur Heart J
|
1994
|
0.81
|
|
4
|
Peak oxygen uptake during exercise in mitral stenosis with sinus rhythm or atrial fibrillation: lack of correlation with valve area. A study in 70 patients.
|
Eur Heart J
|
1994
|
0.78
|
|
5
|
Management of heart failure in the elderly: recommendations from the French Society of Cardiology (SFC) and the French Society of Gerontology and Geriatrics (SFGG).
|
J Nutr Health Aging
|
2006
|
0.77
|
|
6
|
[Epidemiology and prognosis of cardiac insufficiency].
|
Arch Mal Coeur Vaiss
|
2001
|
0.77
|
|
7
|
Protection against ischaemic ventricular fibrillation by blocking agents of myocardial cell calcium influx. Electrophysiological study in the pig in situ heart.
|
Fundam Clin Pharmacol
|
1991
|
0.77
|
|
8
|
Calcium channel modulators and susceptibility to ischaemic ventricular fibrillation: modification of cellular calcium overload.
|
Arch Int Pharmacodyn Ther
|
1992
|
0.77
|
|
9
|
Calcium antagonists and prevention of ventricular fibrillation induced by transient or persistent ischemia.
|
Jpn Heart J
|
1997
|
0.77
|
|
10
|
Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ.
|
Naunyn Schmiedebergs Arch Pharmacol
|
1991
|
0.77
|
|
11
|
Cardiac beta-adrenoreceptor activation and ventricular fibrillation under normal and ischemic conditions.
|
Cardiovasc Res
|
1996
|
0.77
|
|
12
|
[Deep venous thrombosis of the lower limbs. Diagnostic contribution of rheoplethysmography with venous occlusion].
|
Presse Med
|
1984
|
0.75
|
|
13
|
Frequency- and time-dependent depression of ventricular distal conduction by two novel antiarrhythmic drugs, cibenzoline and flecainide.
|
Arch Int Pharmacodyn Ther
|
1988
|
0.75
|
|
14
|
Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
|
Pharmacotherapy
|
1997
|
0.75
|
|
15
|
[Heart failure at the heart of cardiology].
|
Arch Mal Coeur Vaiss
|
2002
|
0.75
|
|
16
|
[Prospective study of the outcome of rheoplethysmographic parameters after deep venous thrombosis of the lower extremities. Role in the decision to discontinue anticoagulants].
|
J Mal Vasc
|
1987
|
0.75
|
|
17
|
[Chronic hemolysis and mitral insufficiency after surgical mitral valvuloplasty. Treatment by valve replacement, a case report].
|
Arch Mal Coeur Vaiss
|
1990
|
0.75
|
|
18
|
Role of asynchronous activation of the ventricular fibres by an ectopic pacemaker in the accidents, especially fibrillation, caused by Ic antiarrhythmic drugs.
|
Fundam Clin Pharmacol
|
1992
|
0.75
|
|
19
|
Time course of electrical fibrillation threshold during brief periods of myocardial ischemia and the genesis of fibrillation: role of calcium.
|
Cardiovasc Drugs Ther
|
1994
|
0.75
|
|
20
|
[Efficacy and tolerability of isoptine LP in mild to moderate hypertension. A multicenter study with 50 patients].
|
Ann Cardiol Angeiol (Paris)
|
1992
|
0.75
|
|
21
|
[Evaluation of a specific French scale of activity in chronic heart failure. A national multicenter study. Group for Cardiac Insufficiency and Cardiomyopathy of the French Society of Cardiology].
|
Arch Mal Coeur Vaiss
|
1999
|
0.75
|
|
22
|
[Arrhythmogenic risk of antiarrhythmic drugs: study with class Ic drugs during myocardial ischemia].
|
Bull Acad Natl Med
|
1991
|
0.75
|
|
23
|
Effects of isoproterenol and propranolol on pharmacologically induced depression of intraventricular conduction.
|
Fundam Clin Pharmacol
|
1989
|
0.75
|
|
24
|
Ventricular and atrial electrophysiological effects of a IC antiarrhythmic drug, cibenzoline, in the innervated dog heart. Role of sodium and calcium channels.
|
Naunyn Schmiedebergs Arch Pharmacol
|
1989
|
0.75
|
|
25
|
Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
|
Arch Int Pharmacodyn Ther
|
1997
|
0.75
|
|
26
|
Delay by a calcium antagonist, amlodipine, of the onset of primary ventricular fibrillation in myocardial ischemia.
|
Cardiovasc Drugs Ther
|
1996
|
0.75
|
|
27
|
Possible prevention by amlodipine of ventricular fibrillation related to brief ischemia episodes.
|
Can J Physiol Pharmacol
|
1996
|
0.75
|
|
28
|
Role of calcium in the rate-dependent depression of atrioventricular nodal conduction in the dog heart under vagal influence.
|
Int J Cardiol
|
1987
|
0.75
|
|
29
|
Biphasic dose-response relationship observed with Bay k 8644 on atrioventricular nodal conduction inhibited by verapamil.
|
Naunyn Schmiedebergs Arch Pharmacol
|
1988
|
0.75
|
|
30
|
[Study of blood pressure, hemodynamic, ventilatory and metabolic responses to isometric exercise performed during dynamic exercise in health subjects].
|
Arch Mal Coeur Vaiss
|
2001
|
0.75
|
|
31
|
[Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
|
Bull Acad Natl Med
|
1996
|
0.75
|
|
32
|
Bupivacaine hastens the ischemia-induced decrease of the electrical ventricular fibrillation threshold.
|
Anesth Analg
|
1995
|
0.75
|
|
33
|
[Informed consent, what information is left after a therapeutic trial?].
|
Arch Mal Coeur Vaiss
|
1994
|
0.75
|
|
34
|
Potentiation by acetylcholine of the effects of a calcium channel activator, Bay k 8644, on dog atria in situ.
|
Naunyn Schmiedebergs Arch Pharmacol
|
1987
|
0.75
|
|
35
|
[The calcium channel in the various elements making up the myocardium].
|
Bull Acad Natl Med
|
1988
|
0.75
|
|
36
|
[Diltiazem and digoxin interaction. Development of digoxin plasma levels and electrocardiographic parameters in healthy subjects].
|
Arch Mal Coeur Vaiss
|
1986
|
0.75
|
|
37
|
[Abnormalities of the peripheral circulation and tolerance to exertion of patients with heart failure].
|
Arch Mal Coeur Vaiss
|
1989
|
0.75
|
|
38
|
[Effect of diltiazem on the serum concentrations of digoxin].
|
Presse Med
|
1984
|
0.75
|
|
39
|
[Improvement of cardiovascular performance during exertion by beta-blockers in mitral stenosis].
|
Presse Med
|
1987
|
0.75
|
|
40
|
[Demonstration of the fibrillatory effect of class I anti-arrhythmia agents based on the time of fibrillation onset and electrical threshold in myocardial ischemia].
|
Therapie
|
1995
|
0.75
|
|
41
|
[Recommendations for the diagnosis and management of cardic failure in the elderly subject].
|
Arch Mal Coeur Vaiss
|
2004
|
0.75
|
|
42
|
[Apical hypertrophic cardiomyopathy].
|
Arch Mal Coeur Vaiss
|
1996
|
0.75
|